AMERISAFE has spent nine straight quarters growing premiums, yet its stock has dropped 21.5% since the last report while the S&P 500 gained 2.7%. That gap frames the third-quarter release. The market is not doubting that this hazardous-industry workers' comp specialist can write business. It is doubting how profitable that business will be as rates keep falling, claim frequency climbs again and competitors push harder for share.
Wall Street expects earnings of $0.47 a share on revenue of $84.8 million. Revenue would be up 3.4% from a year ago, while EPS would fall 14.6% from $0.55. That combination of a modest top-line gain and a sharper earnings decline is the margin squeeze in miniature. The revenue estimate also implies a real slowdown from the 11.4% growth in net premiums earned last quarter. It sits well below the prior quarter's $92.0 million. Management offered no formal financial guidance. It reaffirmed a sustainable mid-single-digit growth path and kept its 72% current accident year loss pick. Consensus fits that slower-growth view, so the bar on volume looks reachable. The harder test is underwriting quality.
The central question from the last call is whether rising claim frequency is a blip or a trend. Through 2025, AMERISAFE could count on frequency falling year after year. At the six-month mark of 2026, management said frequency had moved back toward 2023 levels. Industry medical inflation running around 4% and continued mid-single-digit rate cuts add to the pressure. A held 72% loss pick, along with steady favorable reserve development near the $7.3 million to $7.6 million pace of the first two quarters, would suggest the problem is contained. A higher pick, or prior-year releases sliding further from last year's $8.6 million second-quarter figure, would tell investors the cushion that has supported earnings is thinning.
Two growth drivers deserve scrutiny. Audit premium jumped to $4.1 million last quarter from $1.5 million a year earlier, helped by roughly 4.7% wage growth among insureds. That flatters both revenue and margins, and it is unlikely to grow forever. Retention above 93% is the other pillar. Management described package carriers as more aggressive, a step up from its earlier description of steady competition. A dip in retention or weaker new business would suggest AMERISAFE is giving ground to protect pricing. Steady retention would suggest it is holding share without chasing price. The expense ratio should also improve from 31.8% now that the $700,000 bad-debt write-off is behind it. Net investment income may keep easing as capital returns shrink the asset base.
The more hopeful thread is California's roughly 10% approved advisory rate increase. Management floated it as a possible early sign that the workers' comp pricing cycle is turning, driven by industry-wide medical inflation. It is not yet material to AMERISAFE. Any further color on early 2027 rate indications, which management said point to slightly slower declines, would matter more than the quarter's EPS.
Sentiment has improved from 37.4% bearish to 23.0% bearish, though it remains negative. At $25.34, the stock trades about 20% below its 200-day moving average of $31.51 and closer to its post-earnings low of $23.20 than its high of $33.17. That suggests plenty of caution is already priced in. The report will hinge on whether AMERISAFE can show that rising frequency and softer pricing are being absorbed within its existing loss assumptions. If it can, the selloff looks overdone. If the loss pick moves higher, the market's skepticism will look justified.